Clinical Trial Update: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety and efficacy evaluation of Umbilical Cord Mesenchymal Stem Cell Therapy for patients with Progressive Multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica
• Progressive Multiple Sclerosis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cell Therapy (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Progressive Multiple Sclerosis, Neuromyelitis Optica. | Phase 1, Phase 2 | Status: UNKNOWN